• People with ulcerative colitis and Crohn's colitis have a 2-3x increased colorectal cancer (CRC) risk (on average) compared to the general population
• Surveillance for CRC in IBD is fraught with challenges - there is a much higher Post Colonoscopy Colorectal Cancer (PCCRC) rate in IBD compared to the general population as there is an increased difficulty in detecting and resecting these lesions, as well as an accelerated cancer biology
• Important - high clinical consequence - make a mistake, and your patient may be subjected to unnecessary life-changing surgery or an avoidably high lifetime risk of cancer

Biographies

Professor Matt Rutter

Matt Rutter is Professor of Gastroenterology at Newcastle University and the University Hospital of North Tees in the United Kingdom. He specialises in advanced diagnostic colonoscopy, polypectomy, colorectal cancer screening and surveillance. He sits on the English Bowel Cancer Screening Programme advisory committee. He is founder and ex-chair of the European Society of Gastrointestinal Endoscopy Quality Improvement in Endoscopy committee, founded the UK’s National Endoscopy Database and chairs the UK’s Joint Advisory Group for GI Endoscopy committee and World Endoscopy Organisation interval cancer subcommittee.

He has published and lectured worldwide on quality in endoscopy, screening and colonoscopic surveillance, receiving the British Society of Gastroenterology Hopkins Endoscopy Prize in 2006 and 2020 and the Royal College of Physicians Goulstonian Lectureship in 2008. He co-authored BSG (2010), NICE (UK, 2011), European (ECCO, 2012) and SCENIC (USA, 2015) colitis surveillance guidelines, was the lead author for the BSG/ACPGBI management of large non-pedunculated colorectal polyps guidelines (2015), and lead author for the BSG/ACPGBI/PHE post-polypectomy surveillance guidelines (2020).

He is regional screening lead for quality assurance in colonoscopy and regional (both NHSE North East and Yorkshire, and NENC ICS) endoscopy lead.
 
Dr Misha Kabir

Dr Misha Kabir is a Consultant Gastroenterologist with a specialist interest in IBD at University College London Hospital. She is member of the BSG guideline development group for the latest iteration of the IBD surveillance guidelines and outgoing Chair of the BSG Supporting Women in Gastroenterology committee.